טוען...
Measuring health-related quality of life in patients with rare disease
BACKGROUND: There has been a growing emphasis on health-related quality of life (HRQoL) as an important outcome in rare disease drug development, although its assessment may be useful outside the drug development context, including in clinical applications or natural history studies. Central to asse...
שמור ב:
| הוצא לאור ב: | J Patient Rep Outcomes |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292508/ https://ncbi.nlm.nih.gov/pubmed/34283357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41687-021-00336-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|